Research Article
Comparative Evaluation of the Treatment of COVID-19 with Multicriteria Decision-Making Techniques
Table 2
Complete ranking of COVID-19 treatment options with PROMETHEE.
| Complete ranking | Options | Net flow | Positive flow | Negative flow |
| 1 | Plasma exchange | 0.0268 | 0.0364 | 0.0095 | 2 | Favipravir | 0.0265 | 0.0361 | 0.0096 | 3 | Intravenous immunoglobulin (IVIG) | 0.0199 | 0.0318 | 0.0120 | 4 | Interleukin-1 blocker | 0.0189 | 0.0335 | 0.0135 | 5 | Tocilizumab | 0.0184 | 0.0342 | 0.0158 | 6 | Remdesivir | 0.0177 | 0.0340 | 0.0162 | 7 | Interferon | 0.0139 | 0.0283 | 0.0144 | 8 | Oseltamivir + hydroxychloroquine + azithromycin | −0.0188 | 0.0165 | 0.0352 | 9 | Lopinavir/ritonavir | −0.0348 | 0.0239 | 0.0588 | 10 | Oseltamivir + hydroxychloroquine | −0.0384 | 0.0103 | 0.0487 | 11 | Hydroxychloroquine | −0.0502 | 0.0108 | 0.0609 |
|
|